Logo

Search the Maliki Encyclopedia

Bibliographic Entry FDA. (2014). Guidance for industry: Bioavailability and bioequivalence studies submitted in NDAs or INDs – general  considerations. Diakses   pada   18   November 2020. https://www.fda.gov/files/drugs/published/Bioavailability- and-Bioequivalence-Studies- Submitted-in-NDAs-or-INDs-%E2%80%94-General-Considerations.pdf
Bibliographic Entry

FDA. (2014). Guidance for industry: Bioavailability and bioequivalence studies submitted in NDAs or INDs – general  considerations. Diakses   pada   18   November 2020. https://www.fda.gov/files/drugs/published/Bioavailability- and-Bioequivalence-Studies- Submitted-in-NDAs-or-INDs-%E2%80%94-General-Considerations.pdf